TimeScale Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

TimeScale Financial’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$4.91K	Hold	1,584	–	–	﹤0.01%	433
2023 Q1	$2.2K	Hold	1,584	–	–	﹤0.01%	482
2022 Q4	$3.2K	Hold	1,584	–	–	﹤0.01%	429
2022 Q3	$3K	Hold	1,584	–	–	﹤0.01%	426
2022 Q2	$5K	Hold	1,584	–	–	﹤0.01%	354
2022 Q1	$7K	Buy	1,584 +1,182	+294%	+$5.23K	﹤0.01%	340
2021 Q4	$2K	Hold	402	–	–	﹤0.01%	429
2021 Q3	$2K	Hold	402	–	–	﹤0.01%	424
2021 Q2	$2K	Hold	402	–	–	﹤0.01%	426
2021 Q1	$3K	Hold	402	–	–	﹤0.01%	417
2020 Q4	$2K	Hold	402	–	–	﹤0.01%	369
2020 Q3	$2K	Hold	402	–	–	﹤0.01%	395
2020 Q2	$2K	Buy	+402	New	+$1.66K	﹤0.01%	393

Other funds holding AMRX

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

TimeScale Financial's AMRX Position: Q2 2023 in Review

TimeScale Financial held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2023 at 1,584 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

TimeScale Financial first reported a position in AMRX in Q2 2020 and has held it in 13 quarters since. The position peaked at $7K in Q1 2022. 128 funds tracked by Wall St. Rank hold AMRX as of Q2 2023.

TimeScale Financial held 1,584 shares of Amneal Pharmaceuticals worth $4.91K as of Q2 2023.
TimeScale Financial left its Amneal Pharmaceuticals share count unchanged in Q2 2023.
Amneal Pharmaceuticals made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #433 holding.
TimeScale Financial first reported a position in Amneal Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
TimeScale Financial's Amneal Pharmaceuticals position peaked at $7K in Q1 2022.
128 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.